Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium

Journal of Neurochemistry

Volumn 66, Issue 1, 1996, Pages 74-82

  Hou, Jyh Gong Gabriel ^a   Lin, Leu Fen H ^b   Mytilineou, Catherine ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

1 Methyl 4 phenylpyridinium; Cell culture; Dopaminergic neuron; Glial cell line derived neurotrophic factor; Neuroprotection; Neurotoxicity

Indexed keywords

NEUROTROPIC AGENT;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL GROWTH; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; GLIA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030031116     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66010074.x     Document Type: Article

References (31)

1. Beck K. D., Knüsel B., Winslow J. W., Rosenthal A., Burton L. E., Nikolics K., and Hefti F. (1992) Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium. Neurodegeneration 1, 27-36.
2. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
3. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
4. Casper D., Mytilineou C., and Blum M. (1991) EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci Res. 30, 372-381.
5. Chadi G., Moller A., Rosen L., Janson A. M., Goldstein M., Ögren S.-O., Pettersson R. F., and Fuxe K. (1993) Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp. Brain Res. 97, 145-158.
6. Chiba K., Trevor A., and Castagnoli N. Jr. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-578.
7. Driscoll B. F., Deibler G. E., Law M. J., and Crane A. M. (1993) Damage to neurons in culture following medium change: role of glutamine and extracellular generation of glutamate. J. Neurochem. 61, 1795-1800.
8. Engele J. and Bohn M. C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia J. Neurosci. 11, 3070-3078. [Published erratum appears in J. Neurosci. 1992 Mar; 12, 685.]
9. Finiels-Marlier F., Marini A. M., Williams P., and Paul S. M. (1993) The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro. J. Neurochem. 60, 1968-1971.
10. Heikkila R. H., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224, 1451-1453.
11. Kumpel C., Hoffer B., Strömberg I., Bektesh S., Collins F., and Olson L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59, 791-795.
12. Hyman C., Hofer M., Barde Y. A., Juhasz M., Yancopoulos G. D., Squinto S. P., and Lindsay R. M. (1991a) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
13. Hyman C., Juhasz M., Jackson C., Radziejewski C., and Lindsay R. M. (1991b) Effects of BDNF and NT-3 on dopaminergic and GABAergic neurons in rat ventral mesencephalic cultures. Soc. Neurosci. Abstr. 17, 908.
14. Hynes M. A., Poulsen K., Armanini M., Berkemeier L., Phillips H., and Rosenthal A. (1994) Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37, 144-154.
15. Javitch J. A., D'Amato R. J., Strittmatter S. M., and Snyder S. H. (1985) Parkinsonism inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyndine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
16. Langston J. W., Ballard P., Tetrud J. W., and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
17. Lin L.-F. H., Doherty D. H., Lile J. D., Beklesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
18. Lin L.-F. H., Zhang T. J., Collins F., and Armes L. G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63, 758-768.
19. Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S., and Herkenham M. A. (1984) Intraneuronal generation of a pyridinium metabolite may cause drug induced parkinsonism. Nature 311, 464-467.
20. Mattson M. P. and Rychlik B. (1990) Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J Dev. Neurosci. 8, 399-415.
21. +) in rat dissociated mesencephalic cultures. Brain Res. 597, 233-240.
22. O'Malley E. K., Black I. B., and Dreyfus C. F. (1991) Local support cells promote survival of substantia nigra dopaminergic neurons in culture. Exp. Neurol. 112, 40-48.
23. +: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. J. Neurosci. Res. 34, 382-393.
24. +) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599, 83-97.
25. Petroski R. E., Grierson J. P., Choi Kwon S., and Geller H. M. (1991) Basic fibroblast growth factor regulates the ability of astrocytes to support hypothalamic neuronal survival in vitro. Dev. Biol. 147, 1-13.
26. Schaar D. G., Sieber B. A., Dreyfus C. F., and Black I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 124, 368-371.
27. Spina M B., Squinto S. P., Miller J., Lindsay R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-pyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
28. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., and Humpel C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401-412.
29. Takeshima T., Johnston J. M., and Commissiong J. W. (1994) Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci. 14, 4769-4779.
30. Tomac A., Lindqvist E., Lin L.-F. H., Ögren S. O., Young D., Hoffer B. J., and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
31. Vyas I., Heikkila R. E., and Nicklas W. J. (1986) Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. J. Neurochem. 46, 1501-1507.